FDA OKs novel IV treatment Olinvyk for acute pain

The FDA has approved Olinvyk — the first new IV chemical opioid agonist in decades — for adults with acute pain, the drug’s manufacturer announced.Olinvyk (oliceridine, Trevena) is intended for patients with pain “severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate,” the manufacturer said.Trevena said the safety and efficacy of oliceridine were established in trials totaling 1,535 patients who were older, obese, diabetic and/or had sleep apnea and underwent orthopedic surgery-bunionectomy or plasticRead More

Share on facebook
Share on twitter
Share on linkedin